Abbott To Buy Piramal Generics Unit For $3.7B
Abbott Laboratories announced Friday that it would acquire Indian drugmaker Piramal Healthcare Ltd.'s branded generics business for $3.72 billion....To view the full article, register now.
Already a subscriber? Click here to view full article